These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38452777)

  • 1. Adaptive immune responses are larger and functionally preserved in a hypervaccinated individual.
    Kocher K; Moosmann C; Drost F; Schülein C; Irrgang P; Steininger P; Zhong J; Träger J; Spriewald B; Bock C; Busch DH; Bogdan C; Schubert B; Winkler TH; Tenbusch M; Schuster EM; Schober K
    Lancet Infect Dis; 2024 May; 24(5):e272-e274. PubMed ID: 38452777
    [No Abstract]   [Full Text] [Related]  

  • 2. Covid-19 vaccination: evidence of waning immunity is overstated.
    Scott J; Richterman A; Cevik M
    BMJ; 2021 Sep; 374():n2320. PubMed ID: 34556464
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer.
    Ehmsen S; Asmussen A; Jeppesen SS; Nilsson AC; Østerlev S; Vestergaard H; Justesen US; Johansen IS; Frederiksen H; Ditzel HJ
    Cancer Cell; 2021 Aug; 39(8):1034-1036. PubMed ID: 34348121
    [No Abstract]   [Full Text] [Related]  

  • 4. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution.
    Griffiths EA; Segal BH
    Cancer Cell; 2021 Aug; 39(8):1045-1047. PubMed ID: 34242573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covid-19 vaccines: delivering protective immunity.
    Sewell HF; Agius RM; Kendrick D; Stewart M
    BMJ; 2020 Dec; 371():m4838. PubMed ID: 33334862
    [No Abstract]   [Full Text] [Related]  

  • 7. Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients.
    Spencer EA; Klang E; Dolinger M; Pittman N; Dubinsky MC
    Inflamm Bowel Dis; 2021 Oct; 27(11):1862-1864. PubMed ID: 34427638
    [No Abstract]   [Full Text] [Related]  

  • 8. Could mixing COVID vaccines boost immune response?
    Ledford H
    Nature; 2021 Feb; 590(7846):375-376. PubMed ID: 33547431
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 vaccination and treatment in vulnerable populations.
    Delgoffe GM
    Immunology; 2022 Feb; 165(2):141-142. PubMed ID: 35018636
    [No Abstract]   [Full Text] [Related]  

  • 10. Protective immunity against COVID-19: Unravelling the evidences for humoral vs. cellular components.
    Priyanka ; Choudhary OP; Singh I
    Travel Med Infect Dis; 2021; 39():101911. PubMed ID: 33186686
    [No Abstract]   [Full Text] [Related]  

  • 11. Why Oxford's positive COVID vaccine results are puzzling scientists.
    Callaway E
    Nature; 2020 Dec; 588(7836):16-18. PubMed ID: 33230278
    [No Abstract]   [Full Text] [Related]  

  • 12. Sterilizing Immunity against COVID-19: Developing Helper T cells I and II activating vaccines is imperative.
    Kyei-Barffour I; Addo SA; Aninagyei E; Ghartey-Kwansah G; Acheampong DO
    Biomed Pharmacother; 2021 Dec; 144():112282. PubMed ID: 34624675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Added Benefit of Covid-19 Vaccination after Previous Infection.
    Klein NP
    N Engl J Med; 2022 Mar; 386(13):1278-1279. PubMed ID: 35353966
    [No Abstract]   [Full Text] [Related]  

  • 14. Preserved antibody responses to COVID-19 vaccination and lower odds of developing COVID-19 in adults with severe asthma.
    Rupani H; Edwards D; Chaudhuri R; Smith S; Jackson DJ; Hearn A; Richards J; Moyses H; Kurukulaaratchy RJ; Haitchi HM; Edwards MR; Johnston SL; Djukanovic R
    J Allergy Clin Immunol Pract; 2024 Sep; 12(9):2510-2513.e2. PubMed ID: 38796102
    [No Abstract]   [Full Text] [Related]  

  • 15. SARS-CoV-2 infection confers greater immunity than shots.
    Wadman M
    Science; 2021 Sep; 373(6559):1067-1068. PubMed ID: 34516858
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes.
    Saad-Roy CM; Morris SE; Metcalf CJE; Mina MJ; Baker RE; Farrar J; Holmes EC; Pybus OG; Graham AL; Levin SA; Grenfell BT; Wagner CE
    Science; 2021 Apr; 372(6540):363-370. PubMed ID: 33688062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study.
    Fendler A; Shepherd STC; Au L; Wilkinson KA; Wu M; Byrne F; Cerrone M; Schmitt AM; Joharatnam-Hogan N; Shum B; Tippu Z; Rzeniewicz K; Boos LA; Harvey R; Carlyle E; Edmonds K; Del Rosario L; Sarker S; Lingard K; Mangwende M; Holt L; Ahmod H; Korteweg J; Foley T; Bazin J; Gordon W; Barber T; Emslie-Henry A; Xie W; Gerard CL; Deng D; Wall EC; Agua-Doce A; Namjou S; Caidan S; Gavrielides M; MacRae JI; Kelly G; Peat K; Kelly D; Murra A; Kelly K; O'Flaherty M; Dowdie L; Ash N; Gronthoud F; Shea RL; Gardner G; Murray D; Kinnaird F; Cui W; Pascual J; Rodney S; Mencel J; Curtis O; Stephenson C; Robinson A; Oza B; Farag S; Leslie I; Rogiers A; Iyengar S; Ethell M; Messiou C; Cunningham D; Chau I; Starling N; Turner N; Welsh L; van As N; Jones RL; Droney J; Banerjee S; Tatham KC; O'Brien M; Harrington K; Bhide S; Okines A; Reid A; Young K; Furness AJS; Pickering L; Swanton C; ; Gandhi S; Gamblin S; Bauer DL; Kassiotis G; Kumar S; Yousaf N; Jhanji S; Nicholson E; Howell M; Walker S; Wilkinson RJ; Larkin J; Turajlic S
    Nat Cancer; 2021 Dec; 2():1321-1337. PubMed ID: 34950880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 vaccines mix-and-match: The concept, the efficacy and the doubts.
    Rashedi R; Samieefar N; Masoumi N; Mohseni S; Rezaei N
    J Med Virol; 2022 Apr; 94(4):1294-1299. PubMed ID: 34796525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine-breakthrough infection by the SARS-CoV-2 omicron variant elicits broadly cross-reactive immune responses.
    Zhou R; To KK; Peng Q; Chan JM; Huang H; Yang D; Lam BH; Chuang VW; Cai JP; Liu N; Au KK; Tsang OT; Yuen KY; Chen Z
    Clin Transl Med; 2022 Jan; 12(1):e720. PubMed ID: 35083867
    [No Abstract]   [Full Text] [Related]  

  • 20. Intranasal COVID-19 vaccines: From bench to bed.
    Alu A; Chen L; Lei H; Wei Y; Tian X; Wei X
    EBioMedicine; 2022 Feb; 76():103841. PubMed ID: 35085851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.